{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:24:38Z","timestamp":1786951478474,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jdcr.2026.05.052","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:14:27Z","timestamp":1779808467000},"page":"105-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tapinarof cream 1% for corticosteroid-refractory erythema annulare centrifugum: A first reported case"],"prefix":"10.1016","volume":"74","author":[{"given":"Hamza","family":"Malick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Jaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritin K.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Kivelevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2026.05.052_bib1","series-title":"StatPearls","article-title":"Erythema annulare centrifugum","author":"McDaniel","year":"2024"},{"key":"10.1016\/j.jdcr.2026.05.052_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jdcr.2023.09.028","article-title":"A case of erythema annulare centrifugum cleared with upadacitinib","volume":"42","author":"Foy","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2026.05.052_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdcr.2024.02.004","article-title":"Refractory erythema annulare centrifugum treated with roflumilast","volume":"47","author":"Calderon","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2026.05.052_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jdcr.2021.07.012","article-title":"Refractory erythema annulare centrifugum treated with apremilast","volume":"15","author":"Lee","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jdcr.2026.05.052_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.31128\/AJGP-05-25-7666","article-title":"Not every annular rash is tinea: recognising erythema annulare centrifugum","volume":"55","author":"Aung","year":"2026","journal-title":"Aust J Gen Pract"},{"issue":"7","key":"10.1016\/j.jdcr.2026.05.052_bib6","article-title":"A JAK of all trades: the use of JAKi in a patient with erythema annulare centrifugum","volume":"17","author":"Romisher","year":"2025","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jdcr.2026.05.052_bib7","first-page":"109","article-title":"Erythema annulare centrifugum: a rare case report","volume":"30","author":"Munirah Bulqini","year":"2021","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"10","key":"10.1016\/j.jdcr.2026.05.052_bib8","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdcr.2026.05.052_bib9","series-title":"StatPearls","article-title":"Tapinarof","author":"Elder","year":"2023"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626003279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626003279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:38:09Z","timestamp":1786948689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626003279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":9,"alternative-id":["S2352512626003279"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.05.052","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tapinarof cream 1% for corticosteroid-refractory erythema annulare centrifugum: A first reported case","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}